Black Hawk Acquisition Corp
BKHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002000775
No open-market purchases or sales by Black Hawk Acquisition Corp insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Members of Congress who traded BKHA
No member of Congress has reported a trade in Black Hawk Acquisition Corp since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.